What is an effect of quetiapine in adolescents during the initial months of treatment?

Quetiapine, an atypical antipsychotic, is often prescribed for mood disorders and certain psychiatric conditions in adolescents. During the initial months of treatment, it is crucial to monitor for potential adverse effects, particularly concerning suicidal ideation. Studies have indicated that adolescents can experience an increase in suicidal thoughts, especially when starting new psychotropic medications, including quetiapine. This is particularly significant during the early treatment phase due to the drug's effects on neurotransmitter systems and the destabilization of mood that can sometimes occur.

The emphasis on monitoring for suicidal ideation is supported by clinical guidelines, which recommend that healthcare providers remain vigilant and conduct regular assessments of mental health, especially during the initial stages of treatment with antipsychotics. It is essential to perform this monitoring due to the complex interplay between mental health conditions and the effects of medications, as well as the developmental factors influencing adolescents' mental health.

The other effects listed, such as increased interest in social activities, improved academic performance, or decreased anxiety symptoms, are not commonly linked to the early treatment phase with quetiapine. Instead, they might be goals of therapy that could be observed if the medication takes effect or if the individual is stabilized over more extended treatment periods. Thus,